02.12.2021 • News

Azelis Acquires Austria’s Neupert Specialities

Azelis has acquired Neupert Specialities, an Austrian distributor specializing in food and health raw materials and ingredients in its local market, as well as in Germany and Switzerland. The deal strengthens the Belgium-based distributor’s presence in the growing Austrian food and health segment and in the region’s broader life sciences market, also adding cross-selling opportunities.

Financial details of the transaction were not disclosed.

“There is an outstanding compatibility between our two companies and we are very excited about the enhanced opportunity to expand the business under Azelis’ ownership by leveraging combined global principal relationships. Azelis’ strong track record in sustainability, especially their EcoVadis Platinum rating, as well as the technological capabilities, are of particularly great value to our joint food and health customer base,” said Peter Suppan, Neupert’s founder and managing director.

Headquartered in Vienna, Neupert specializes in products such as proteins, hydrocolloids, agar and sugar substitutes. The company was founded by Suppan and Norbert Resch, both of whom will continue to lead the business.

In late October, Azelis also agreed to acquire 90% of the shares in South Africa’s Umongo, a leading distributor of lubricants and metal working fluids. The transaction is expected to close by the end of this year. Umongo has its head office in Durban and employs 35 people. It also has an application laboratory. CEO Boston Moonsamy will remain with the company and continue to lead the business.

Author: Elaine Burridge, Freelance Journalist

(c) Azelis
(c) Azelis

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.